CD8A and neoplasm: The pan-caspase inhibitor Z-VAD (OH)-FMK (zVAD) has been reported to induce necroptosis in melanoma via reducing tumor infiltration by regulatory T cells (Tregs) while increasing DC and CD8+ T cells to reduce tumor growth (Werthmöller et al., 2015).